Filing Details
- Accession Number:
- 0001209191-20-002338
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 18:18:40
- Reporting Period:
- 2020-01-03
- Accepted Time:
- 2020-01-07 18:18:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Therapeutics Public Ltd Co | HZNP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1349376 | P Timothy Walbert | C/O Horizon Therapeutics Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-01-05 | 211,000 | $0.00 | 987,991 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2020-01-05 | 168,523 | $0.00 | 1,156,514 | No | 4 | A | Direct | |
| Ordinary Shares | Disposition | 2020-01-05 | 168,319 | $36.10 | 988,195 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2020-01-06 | 84,886 | $35.57 | 903,309 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units (RSU) | Acquisiton | 2020-01-03 | 174,165 | $0.00 | 174,165 | $0.00 |
| Ordinary Shares | Restricted Stock Units (RSU) | Acquisiton | 2020-01-03 | 10,159 | $0.00 | 10,159 | $0.00 |
| Ordinary Shares | Restricted Stock Units (RSU) | Disposition | 2020-01-05 | 58,034 | $0.00 | 58,034 | $0.00 |
| Ordinary Shares | Restricted Stock Units (RSU) | Disposition | 2020-01-05 | 152,966 | $0.00 | 152,966 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 174,165 | No | 4 | A | Direct | ||
| 10,159 | No | 4 | A | Indirect | ||
| 116,070 | No | 4 | M | Direct | ||
| 152,967 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 1,049 | Indirect | By spouse |
Footnotes
- Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- On January 5, 2018, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2020, the PSUs vested as to the number of shares reported above.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2019.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.48 to $35.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Includes 1,049 ordinary shares of the Issuer acquired by the reporting person's spouse on November 29, 2019 pursuant to an employee stock purchase program.
- The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
- The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
- The RSU's vest 1/3rd annually on each anniversary of January 5, 2018.
Billionaire Hedge Funds
